SCHEMBL17863528

SCHEMBL17863528

CC1(C)c2c(ccc3cc(N(c4ccc5c6c(ccc5c4)-c4c(c5ccccc5c5ccccc45)C6(C)C)c4cccc5c4oc4ccccc45)ccc23)-c2c1c1ccccc1c1ccccc21

nearest known ligand 0.33

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 2/20 0.33
▸ PGR P06401 1/20 0.33
▸ MEN1 O00255 1/20 0.31
▸ CYP2C19 P33261 1/20 0.31
▸ KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17863487 0.97 ALOX5 (0.32) ALOX5PGR
SCHEMBL17863437 0.97 ALOX5 (0.32) ALOX5PGR
SCHEMBL17863066 0.96 ALOX5 (0.31) ALOX5PGR
SCHEMBL17863084 0.94 PGR (0.32) ALOX5PGR
SCHEMBL17863089 0.94 ALOX5 (0.31) ALOX5
SCHEMBL17863080 0.94 PGR (0.31) PGR
SCHEMBL17863518 0.93 ALK (0.31) —
SCHEMBL17863081 0.93 — —
SCHEMBL17863078 0.93 PGR (0.32) ALOX5PGR
SCHEMBL17863416 0.92 ALOX5 (0.31) ALOX5PGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10396288-B2 Organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2019-08-27 — — US disclosed
US-20160181543-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2016-06-23 — — US disclosed
US-20160181543-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2016-06-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10396288-B2 Organic electroluminescent element and electronic device RER1, LEF1, ELP1 ALOX5 1328/4885PGR 1620/4885MEN1 2446/4885
US-20160181543-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE RER1, LEF1, RPL18 ALOX5 1331/4885PGR 1639/4885MEN1 2490/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback